ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects

NCT03687632 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Persistent Corneal Epithelial Defect

Interventions

BIOLOGICAL: ST266

Sponsor

Noveome Biotherapeutics, formerly Stemnion